H. Teschemacher

3.3k total citations · 1 hit paper
34 papers, 2.6k citations indexed

About

H. Teschemacher is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, H. Teschemacher has authored 34 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in H. Teschemacher's work include Neuropeptides and Animal Physiology (12 papers), Receptor Mechanisms and Signaling (8 papers) and Protein Hydrolysis and Bioactive Peptides (7 papers). H. Teschemacher is often cited by papers focused on Neuropeptides and Animal Physiology (12 papers), Receptor Mechanisms and Signaling (8 papers) and Protein Hydrolysis and Bioactive Peptides (7 papers). H. Teschemacher collaborates with scholars based in Germany and United States. H. Teschemacher's co-authors include Brian M. Cox, Avram Goldstein, K E Opheim, A. Herz, Lothar Schweigerer, Sucharit Bhakdi, V. Brantl, F. Lottspeich, Agnes Henschen and W. Krömer and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

H. Teschemacher

33 papers receiving 2.4k citations

Hit Papers

Purification and properties 1975 2026 1992 2009 1975 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Purification and properties
    1975 1.4k citations Brian M. Cox, K E Opheim et al. Life Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Teschemacher Germany 17 1.6k 877 385 242 198 34 2.6k
Oscar A. Candia United States 27 2.9k 1.8× 567 0.6× 341 0.9× 270 1.1× 176 0.9× 135 4.4k
W. Carson Brown United States 22 918 0.6× 539 0.6× 302 0.8× 216 0.9× 126 0.6× 45 2.7k
Jaime Renau‐Piqueras Spain 38 1.9k 1.2× 727 0.8× 422 1.1× 112 0.5× 265 1.3× 131 4.3k
W Tampion United Kingdom 10 1.4k 0.9× 487 0.6× 449 1.2× 80 0.3× 101 0.5× 15 2.2k
Barbara Wróblewska Poland 32 1.7k 1.1× 1.3k 1.5× 487 1.3× 274 1.1× 213 1.1× 138 3.7k
J.M. Young United Kingdom 34 2.5k 1.6× 946 1.1× 551 1.4× 246 1.0× 96 0.5× 127 5.0k
Tadashi Yasuhara Japan 35 1.8k 1.1× 822 0.9× 362 0.9× 255 1.1× 91 0.5× 118 3.4k
Indrajit Das United Kingdom 29 1.3k 0.8× 310 0.4× 460 1.2× 182 0.8× 171 0.9× 93 3.2k
M Impicciatore Italy 28 949 0.6× 892 1.0× 339 0.9× 235 1.0× 160 0.8× 123 2.8k
Sophia Diamant Israel 23 1.6k 1.0× 334 0.4× 344 0.9× 163 0.7× 75 0.4× 40 2.4k

Countries citing papers authored by H. Teschemacher

Since Specialization
Citations

This map shows the geographic impact of H. Teschemacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Teschemacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Teschemacher more than expected).

Fields of papers citing papers by H. Teschemacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Teschemacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Teschemacher. The network helps show where H. Teschemacher may publish in the future.

Co-authorship network of co-authors of H. Teschemacher

This figure shows the co-authorship network connecting the top 25 collaborators of H. Teschemacher. A scholar is included among the top collaborators of H. Teschemacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Teschemacher. H. Teschemacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teschemacher, H.. (2003). Opioid Receptor Ligands Derived from Food Proteins. Current Pharmaceutical Design. 9(16). 1331–1344. 150 indexed citations
2.
Schulz, Axel, et al.. (2000). β-Endorphin Immunoreactive Material and Authentic β-Endorphin in the Plasma of Males Undergoing Anaerobic Exercise on a Rowing Ergometer. International Journal of Sports Medicine. 21(7). 513–517. 15 indexed citations
3.
Welters, Ingeborg, A. Menzebach, Yannick Goumon, et al.. (2000). Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and μ3 opiate receptor-dependent mechanism. Journal of Neuroimmunology. 111(1-2). 139–145. 81 indexed citations
4.
Hartwig, A., H. Teschemacher, Wolf D. Lehmann, Matthias Gauly, & G. Erhardt. (1997). VII.3 - Influence of genetic polymorphisms in bovine milk on the occurrence of bioactive peptides. 459–460. 18 indexed citations
5.
Hildebrand, A., Lothar Schweigerer, & H. Teschemacher. (1988). Characterization and identification of heparin-induced nonopioid-binding sites for beta-endorphin in human plasma.. Journal of Biological Chemistry. 263(5). 2436–2441. 16 indexed citations
6.
Teschemacher, H. & G. Koch. (1983). Opioids in milk. Trends in Pharmacological Sciences. 4(3). 193–193. 32 indexed citations
7.
Schweigerer, Lothar, Sucharit Bhakdi, & H. Teschemacher. (1982). Specific non-opiate binding sites for human β-endorphin on the terminal complex of human complement. Nature. 296(5857). 572–574. 72 indexed citations
8.
Brantl, V. & H. Teschemacher. (1979). A material with opioid activity in bovine milk and milk products. Naunyn-Schmiedeberg s Archives of Pharmacology. 306(3). 301–304. 58 indexed citations
9.
Rust, M, et al.. (1979). Elevated plasma β-endorphin levels in pregnant women and their neonates. Life Sciences. 25(10). 835–844. 111 indexed citations
10.
Cox, Brian M., K E Opheim, H. Teschemacher, & Avram Goldstein. (1975). Purification and properties. Life Sciences. 16(12). 1777–1782. 1361 indexed citations breakdown →
11.
Teschemacher, H., K E Opheim, Brian M. Cox, & Avram Goldstein. (1975). Isolation. Life Sciences. 16(12). 1771–1775. 202 indexed citations
12.
Teschemacher, H., et al.. (1974). Proceedings: Site of action of morphine in the development of physical dependence in rats.. PubMed. 282(Suppl). suppl 282:R54–suppl 282:R54. 2 indexed citations
13.
Teschemacher, H.. (1970). [Permeation behavior of morphine-like substances after intraventricular and intracerebral injection].. PubMed. 266(4). 466–7. 1 indexed citations
14.
Teschemacher, H., et al.. (1969). Vergleich der analgetischen Wirkung morphinartiger Substanzen bei intraven�ser und bei intraventrikul�rer Applikation im Hinblick auf ihre Lipoidl�slichkeit. Naunyn-Schmiedeberg s Archives of Pharmacology. 263(1). 199–200. 2 indexed citations
15.
Teschemacher, H., et al.. (1968). Permeation of purine derivatives into the cerebrospinal fluid of dogs. Cellular and Molecular Life Sciences. 24(1). 54–55. 16 indexed citations
16.
Hess, R., H. Teschemacher, & A. Herz. (1968). �ber die Permeation von Xanthinderivaten in Gehirn und Liquor in Abh�ngigkeit von Lipoidl�slichkeit, Gewebsbindung und Stoffwechsel. Naunyn-Schmiedeberg s Archives of Pharmacology. 261(5). 469–485. 14 indexed citations
17.
Herz, A., et al.. (1968). Vergleichende Untersuchungen �ber zentrale Wirkungen von Xanthinderivaten in Hinblick auf deren Stoffwechsel und Verteilung im Organismus. Naunyn-Schmiedeberg s Archives of Pharmacology. 261(5). 486–502. 20 indexed citations
18.
Herz, A., et al.. (1967). CENTRAL NICOTINE‐AND MUSCARINELIKE PROPERTIES OF CHOLINOMIMETIC DRUGS WITH REGARD TO THEIR LIPID SOLUBILITIES. Annals of the New York Academy of Sciences. 142(1). 21–26. 7 indexed citations
19.
Herz, A., et al.. (1966). Zentrale und periphere Wirkungen von Cholinomimetica und ihre Abh�ngigkeit von der Lipoidl�slichkeit. Naunyn-Schmiedeberg s Archives of Pharmacology. 253(2). 10 indexed citations
20.
Herz, A., H. Teschemacher, Amelia R. Hofstetter, & Herbert Kurz. (1965). The importance of lipid-solubility for the central action of cholinolytic drugs. International Journal of Neuropharmacology. 4(4). 207–218. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oscar A. Candia Breakdown of academic impact, for papers by W. Carson Brown Breakdown of academic impact, for papers by Jaime Renau‐Piqueras Breakdown of academic impact, for papers by W Tampion Breakdown of academic impact, for papers by Barbara Wróblewska Breakdown of academic impact, for papers by J.M. Young Breakdown of academic impact, for papers by Tadashi Yasuhara Breakdown of academic impact, for papers by Indrajit Das Breakdown of academic impact, for papers by M Impicciatore Breakdown of academic impact, for papers by Sophia Diamant
Rankless by CCL
2026